New Home-Mid Content


The King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions.

We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.

More about the Centre


With the next generation of oral anticoagulants entering clinical practice, the FIRST registry will provide an important data tool to increase knowledge and improve the quality of care of patients with VTE.

More about the Registry


The King’s Thrombosis Centre runs this training course twice a year, which was developed to meet the educational needs of healthcare professionals involved in anticoagulation management. Click here to download an application form and agenda.

For further information, contact Dr Raj Patel


After being hosted at the King's Thrombosis Centre website since its launch in 2007, the website is now managed as part of the National VTE prevention Programme at NHS England. Click the image to access the site.

Latest News

  • Anticoagulation news items. Weeks commencing 16th January 2017
    Revised SPC: Dipyridamole 50mg/5ml Oral Suspension electronic Medicines Compendium Angina pectoris, post procedural haemorrhage and operative haemorrhage have been added as adverse reactions of dipyridamole.   Revised SPC: Nebido (testosterone…
  • Anticoagulation news items. Weeks commencing 9th January 2017
    Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience JAMA Cardiology Research letter-reports on study (n=734) which showed high rate of discontinuation of…
  • Anticoagulation news items. Weeks commencing 3rd January 2017
    Thrombolysis for acute deep vein thrombosis Cochrane Database of Systematic Reviews Evidence suggests that systemic administration and catheter-directed thrombolysis have similar effectiveness. Strict eligibility criteria may be necessary to reduce…